Prabhavathi Fernandes
CIK 1540883 · President and CEO · last filed 2024-12-02
Prabhavathi Fernandes is a President and CEO who has filed 19 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing shows the insider bought $9.1K of OCGN on Dec 2, 2024. Across all open-market trades the lifetime net is −$587.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.1K
3
19
-$587.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OCGN | Director | 10,000 | $1.21 | $12.1K | -$265.7K | 8 | 2024-12-02 |
| OPGEN INC (OPGN) Delisted | Director | 3,000 | $24.75 | $74.2K | $0 | 4 | 2023-06-09 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | President and CEO | 247,678 | — | — | -$321.5K | 7 | 2016-01-05 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-02 | OCGN | Buy (P) | +10,000 | $9.1K | EDGAR |
| 2024-07-02 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | OPGEN INC (OPGN) Delisted | Grant (A) | +1,500 | $0 | EDGAR |
| 2022-06-10 | OPGEN INC (OPGN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2022-06-08 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2021-12-17 | OCGN | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | OPGEN INC (OPGN) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2021-05-27 | OCGN | Mixed | — | -$243.7K | EDGAR |
| 2021-01-04 | OCGN | Grant (A) | — | $0 | EDGAR |